Fennec Pharmaceuticals (FENC) Other Non-Current Liabilities (2010 - 2018)
Fennec Pharmaceuticals posted quarterly Other Non-Current Liabilities of $167000.0 for Q2 2018, up 206.37% year-on-year from $54509.4 in Q2 2017, and little changed on a QoQ basis from $167000.0 in Q4 2017.
Fennec Pharmaceuticals (FENC) has 9 years of Other Non-Current Liabilities data on file, last reported at $167000.0 in Q2 2018.
- For the quarter ending Q2 2018, Other Non-Current Liabilities rose 206.37% year-over-year to $167000.0; the trailing twelve-month figure through Jun 2018 stood at $167000.0 (up 206.37% YoY), and the FY2017 full-year result was $167000.0, up 406.06% from the prior year.
- Other Non-Current Liabilities for Q2 2018 stood at $167000.0, roughly flat from $167000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $5.5 million in Q1 2014 and bottomed at -$157000.0 in Q2 2017.
- The 5-year median for Other Non-Current Liabilities is $167000.0 (2017), against an average of $1.2 million.
- The widest annual swing landed in 2014, when Other Non-Current Liabilities jumped 2342.59%; it then slumped 97.34% in 2015.
- A 5-year view of Other Non-Current Liabilities shows it stood at $1.3 million in 2014, then tumbled by 93.78% to $82000.0 in 2015, then sank by 59.76% to $33000.0 in 2016, then soared by 406.06% to $167000.0 in 2017, then changed by 0.0% to $167000.0 in 2018.
- The last three Other Non-Current Liabilities figures came in at $167000.0 (Q2 2018), $167000.0 (Q4 2017), and -$157000.0 (Q2 2017), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 167,000.00 |
| Dec 31, 2017 | 167,000.00 |
| Jun 30, 2017 | -157,000.00 |
| Mar 31, 2017 | 71,000.00 |
| Dec 31, 2016 | 33,000.00 |
| Mar 31, 2016 | 39,000.00 |
| Dec 31, 2015 | 82,000.00 |
| Sep 30, 2015 | 93,000.00 |
| Jun 30, 2015 | 309,000.00 |
| Mar 31, 2015 | 694,000.00 |
| Dec 31, 2014 | 1.32 Mn |
| Sep 30, 2014 | 3.50 Mn |
| Jun 30, 2014 | 5.34 Mn |
| Mar 31, 2014 | 5.52 Mn |
| Dec 31, 2013 | 54,000.00 |
| Dec 31, 2012 | 96,000.00 |
| Dec 31, 2011 | 108,000.00 |
| Dec 31, 2010 | 86,000.00 |